PERCEPTIVE ADVISORS LLC
Q1 2020 13F-HR/A Holdings
Net value change ($000)
-1,194,581
(-23.7%)
New positions
24
Sold out positions
25
Turnover %
13.7%
Sector allocation + QoQ delta (equities-only)
Snapshot: Change Analysis
Compared to Q4 2019
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| IOVA | 88,703 | 34.0% |
| BBIO | 52,208 | 36.7% |
| REGN | 39,063 | NEW |
| BDTX | 27,561 | NEW |
| TBPH | 23,110 | NEW |
| NEVRO CORP | 17,662 | 19.7% |
| VYNE | 17,456 | NEW |
| ZYMEWORKS INC | 16,851 | 15.4% |
| COLL | 16,669 | 192.3% |
| DNLI | 14,884 | NEW |
Top Reduces (Value $000, Stocks/ETFs)
| Mirati Therapeutics, Inc. | -157,624 | -38.2% |
| Global Blood Therapeutics, Inc. | -156,369 | -33.5% |
| AMARIN CORP PLC | -152,355 | -100.0% |
| NBIX | -123,187 | -31.7% |
| ZOGENIX, INC. | -107,968 | -55.8% |
| KOD | -88,841 | -33.7% |
| Athenex, Inc. | -86,839 | -49.3% |
| QUOTIENT LTD | -73,887 | -58.5% |
| MOMENTA PHARMACEUTICALS INC | -55,066 | -98.4% |
| MGTX | -42,331 | -32.9% |
Instrument mix + QoQ Δ (ex-options)
Derivatives reported exposure ($000):
1,032
(0.0% of total reported value)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|